MedPath

The effect of Aspirin on breast cancer recurrence

Phase 2
Conditions
Breast cancer.
Nipple and areola, Central portion of breast, Upper-inner quadrant of breast, Lower-inner quadrant of breast, Upper-outer quadrant of breast, Lower-outer quadrant of breast, Axillary tail of breast, Overlapping lesion of breast, Breast, unspecified
C50.0 , C5
Registration Number
IRCT201202218215N1
Lead Sponsor
Vice chancellor for research, Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
400
Inclusion Criteria

Breast cancer patients in stage 1 , 2 and 3 and surgical and adjuvant treatments have been completed;
Exclusion criteria: Patients who experience gastrointestinal problems and are sensitive to Aspirin are excluded.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical examination. Timepoint: 2 years. Method of measurement: Clinical examination.
Secondary Outcome Measures
NameTimeMethod
Mammography. Timepoint: 2 years. Method of measurement: Mammography.
© Copyright 2025. All Rights Reserved by MedPath